MyMD Announces U.S. Drug Enforcement Administration Determines Supera-CBD is not a Controlled Substance or Listed Chemical
| MYMDDelisted Stock | USD 1.82 0.02 1.09% |
About 62% of MYMD Old's investor base is looking to short. The analysis of current outlook of investing in MYMD Old suggests that many traders are alarmed regarding MYMD Old's prospects. The current market sentiment, together with MYMD Old's historical and current headlines, can help investors time the market. In addition, many technical investors use MYMD Old stock news signals to limit their universe of possible portfolio assets.
MYMD |
BALTIMORE, March 02, 2023--MyMD Pharmaceuticals, Inc. , a clinical stage biopharmaceutical company developing groundbreaking therapies for the treatment of serious and debilitating autoimmune and inflammatory diseases, today announced that the U.S. Drug Enforcement Administration has conducted a scientific review and determined that investigational cannabinoid Supera-CBD is not currently considered a controlled substance or listed chemical. The sci
Read at finance.yahoo.com
 |
MYMD Old Fundamental Analysis
We analyze MYMD Old's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of MYMD Old using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of MYMD Old based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash Flow From Operations
Cash Flow From Operations Comparative Analysis
MYMD Old is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
MYMD Old Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with MYMD Old stock to make a market-neutral strategy. Peer analysis of MYMD Old could also be used in its relative valuation, which is a method of valuing MYMD Old by comparing valuation metrics with similar companies.
Peers
MYMD Old Related Equities
| ORIC | Oric Pharmaceuticals | 4.84 | ||||
| NVCT | Nuvectis Pharma | 2.75 | ||||
| LYEL | Lyell Immunopharma | 2.72 | ||||
| LGND | Ligand Pharmaceuticals | 1.96 | ||||
| DSGN | Design Therapeutics | 1.81 | ||||
| KRON | Kronos Bio | 0.98 | ||||
| PASG | Passage Bio | 0.77 | ||||
| REPL | Replimune | 0.74 | ||||
| KZR | Kezar Life | 0.63 | ||||
| BOLT | Bolt Biotherapeutics | 0.29 | ||||
| AVIR | Atea Pharmaceuticals | 0.32 | ||||
| SRZN | Surrozen | 0.71 | ||||
| GOSS | Gossamer Bio | 1.08 | ||||
| LYRA | Lyra Therapeutics | 1.63 | ||||
| XBIO | Xenetic Biosciences | 2.35 | ||||
| KROS | Keros Therapeutics | 3.29 | ||||
| LRMR | Larimar Therapeutics | 3.35 | ||||
| RXRX | Recursion Pharmaceuticals | 3.96 | ||||
| GOVX | GeoVax Labs | 6.28 | ||||
| NBY | NovaBay Pharmaceuticals | 6.74 | ||||
| UBX | Unity Biotechnology | 9.66 | ||||
| REVB | Revelation Biosciences | 93.93 |
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Consideration for investing in MYMD Stock
If you are still planning to invest in MYMD Old check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MYMD Old's history and understand the potential risks before investing.
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| CEOs Directory Screen CEOs from public companies around the world | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |